These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
929 related articles for article (PubMed ID: 34331036)
1. Cell death in pancreatic cancer: from pathogenesis to therapy. Chen X; Zeh HJ; Kang R; Kroemer G; Tang D Nat Rev Gastroenterol Hepatol; 2021 Nov; 18(11):804-823. PubMed ID: 34331036 [TBL] [Abstract][Full Text] [Related]
2. Emerging Potential Mechanism and Therapeutic Target of Ferroptosis in PDAC: A Promising Future. Li C; Yin X; Liu Z; Wang J Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499358 [TBL] [Abstract][Full Text] [Related]
3. Small-Molecule MMRi62 Induces Ferroptosis and Inhibits Metastasis in Pancreatic Cancer via Degradation of Ferritin Heavy Chain and Mutant p53. Li J; Lama R; Galster SL; Inigo JR; Wu J; Chandra D; Chemler SR; Wang X Mol Cancer Ther; 2022 Apr; 21(4):535-545. PubMed ID: 35131878 [TBL] [Abstract][Full Text] [Related]
4. Oncogene ablation-resistant pancreatic cancer cells depend on mitochondrial function. Viale A; Pettazzoni P; Lyssiotis CA; Ying H; Sánchez N; Marchesini M; Carugo A; Green T; Seth S; Giuliani V; Kost-Alimova M; Muller F; Colla S; Nezi L; Genovese G; Deem AK; Kapoor A; Yao W; Brunetto E; Kang Y; Yuan M; Asara JM; Wang YA; Heffernan TP; Kimmelman AC; Wang H; Fleming JB; Cantley LC; DePinho RA; Draetta GF Nature; 2014 Oct; 514(7524):628-32. PubMed ID: 25119024 [TBL] [Abstract][Full Text] [Related]
5. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia. McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621 [TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of multiple pancreatic cancers involves multicentric carcinogenesis and intrapancreatic metastasis. Fujita Y; Matsuda S; Sasaki Y; Masugi Y; Kitago M; Yagi H; Abe Y; Shinoda M; Tokino T; Sakamoto M; Kitagawa Y Cancer Sci; 2020 Feb; 111(2):739-748. PubMed ID: 31799787 [TBL] [Abstract][Full Text] [Related]
7. SOX9 activity is induced by oncogenic Kras to affect MDC1 and MCMs expression in pancreatic cancer. Zhou H; Qin Y; Ji S; Ling J; Fu J; Zhuang Z; Fan X; Song L; Yu X; Chiao PJ Oncogene; 2018 Feb; 37(7):912-923. PubMed ID: 29059173 [TBL] [Abstract][Full Text] [Related]
8. Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma. Murakami S; Shahbazian D; Surana R; Zhang W; Chen H; Graham GT; White SM; Weiner LM; Yi C Oncogene; 2017 Mar; 36(9):1232-1244. PubMed ID: 27546622 [TBL] [Abstract][Full Text] [Related]
9. Exploiting the ferroaddiction of pancreatic cancer cells using Fe-doped nanoparticles. Lomphithak T; Sae-Fung A; Sprio S; Tampieri A; Jitkaew S; Fadeel B Nanomedicine; 2024 Jan; 55():102714. PubMed ID: 38738528 [TBL] [Abstract][Full Text] [Related]
10. Oncogenic ERBB2 aberrations and KRAS mutations cooperate to promote pancreatic ductal adenocarcinoma progression. Li Z; Shao C; Liu X; Lu X; Jia X; Zheng X; Wang S; Zhu L; Li K; Pang Y; Xie F; Lu Y; Wang Y Carcinogenesis; 2020 Mar; 41(1):44-55. PubMed ID: 31046123 [TBL] [Abstract][Full Text] [Related]
11. MST1 Suppresses Pancreatic Cancer Progression via ROS-Induced Pyroptosis. Cui J; Zhou Z; Yang H; Jiao F; Li N; Gao Y; Wang L; Chen J; Quan M Mol Cancer Res; 2019 Jun; 17(6):1316-1325. PubMed ID: 30796177 [TBL] [Abstract][Full Text] [Related]
12. Chronic inflammation initiates multiple forms of K-Ras-independent mouse pancreatic cancer in the absence of TP53. Swidnicka-Siergiejko AK; Gomez-Chou SB; Cruz-Monserrate Z; Deng D; Liu Y; Huang H; Ji B; Azizian N; Daniluk J; Lu W; Wang H; Maitra A; Logsdon CD Oncogene; 2017 Jun; 36(22):3149-3158. PubMed ID: 27991926 [TBL] [Abstract][Full Text] [Related]
13. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1. Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830 [TBL] [Abstract][Full Text] [Related]
14. Wild type and gain of function mutant TP53 can regulate the sensitivity of pancreatic cancer cells to chemotherapeutic drugs, EGFR/Ras/Raf/MEK, and PI3K/mTORC1/GSK-3 pathway inhibitors, nutraceuticals and alter metabolic properties. McCubrey JA; Meher AK; Akula SM; Abrams SL; Steelman LS; LaHair MM; Franklin RA; Martelli AM; Ratti S; Cocco L; Barbaro F; Duda P; Gizak A Aging (Albany NY); 2022 Apr; 14(8):3365-3386. PubMed ID: 35477123 [TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity for Kras Ma Y; Li Y; Ling S; Li X; Kong B; Hu M; Huang P Biochem Biophys Res Commun; 2020 Jun; 526(4):880-888. PubMed ID: 32279996 [TBL] [Abstract][Full Text] [Related]
16. Pancreatic cancer cell lines as patient-derived avatars: genetic characterisation and functional utility. Knudsen ES; Balaji U; Mannakee B; Vail P; Eslinger C; Moxom C; Mansour J; Witkiewicz AK Gut; 2018 Mar; 67(3):508-520. PubMed ID: 28073890 [TBL] [Abstract][Full Text] [Related]
17. The Roles of Frequently Mutated Genes of Pancreatic Cancer in Regulation of Tumor Microenvironment. Sun H; Zhang B; Li H Technol Cancer Res Treat; 2020; 19():1533033820920969. PubMed ID: 32372692 [TBL] [Abstract][Full Text] [Related]
18. KLF10 loss in the pancreas provokes activation of SDF-1 and induces distant metastases of pancreatic ductal adenocarcinoma in the Kras Weng CC; Hawse JR; Subramaniam M; Chang VHS; Yu WCY; Hung WC; Chen LT; Cheng KH Oncogene; 2017 Sep; 36(39):5532-5543. PubMed ID: 28581520 [TBL] [Abstract][Full Text] [Related]
19. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. Biffi G; Oni TE; Spielman B; Hao Y; Elyada E; Park Y; Preall J; Tuveson DA Cancer Discov; 2019 Feb; 9(2):282-301. PubMed ID: 30366930 [TBL] [Abstract][Full Text] [Related]
20. Docosahexaenoic acid inhibits the proliferation of Kras/TP53 double mutant pancreatic ductal adenocarcinoma cells through modulation of glutathione level and suppression of nucleotide synthesis. Hung WC; Lee DY; Chiang EI; Syu JN; Chao CY; Yang MD; Tsai SY; Tang FY PLoS One; 2020; 15(11):e0241186. PubMed ID: 33137095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]